Once A Component of Agent Orange, 2,4-D Herbicide Could Spark A Surge in Enlist Crops

The controversial defoliant manufactured by The Dow Chemical Company and Monsanto for the U.S. Department of Defense during the Vietnam War is rumored to be making a comeback in the form of new engineered crop varieties. Are the rumblings true or just another overblown misconception from the GMO food debate?

Jan 12, 2014 at 2:05PM

Images

Huey helicopters were used to disperse Agent Orange across forests and farms in over 6,500 missions in a nine year period of the Vietnam War. Image source: Wikimedia Commons

The use of Agent Orange, one of the nine Rainbow Herbicides used to destroy forests and farmland during the Vietnam War, is one of the darkest chapters in American history. It wasn't the first time herbicidal warfare had been conducted, but it was the first time such tactics were carried out on an industrial scale. The chemical, supplied by Monsanto (NYSE:MON) and Dow Chemical (NYSE:DOW), was a mixture of two herbicides: 2,4,5-T and 2,4-D. The former was phased-out of field use more than 30 years ago due to toxicity concerns, while the latter has become the most widely used herbicide on the planet.  

The fact that 2,4-D is an important tool in modern agricultural may be a surprise to some, especially given the contentious history of Agent Orange. That may also make a recent recommendation by the U.S. Department of Agriculture to allow Enlist corn and soybean varieties created by Dow AgroSciences, that are resistant to the herbicide, to be marketed in the United States. Considering that 60%-70% of processed foods contain ingredients produced from genetically modified organisms, or GMOs, should you be concerned? 

Time to panic?
Not so fast. As stated above, the herbicide 2,4-D is not Agent Orange. Nor was it the component that made the most widely used Rainbow Herbicide highly toxic to humans. It was later discovered that the industrial process used to produce 2,4,5-T -- the other half of Agent Orange -- also produced highly carcinogenic compounds called dioxins.

So, to be clear, there is no link between 2,4-D and cancer. In fact, a 2007 review by the U.S. Environmental Protection Agency concluded that "the weight of the evidence does not support a conclusion that (2,4-D compounds) are likely human carcinogens." The chemical has been reviewed numerous times by the EPA, top-ranked environmental academic institutions such as Oregon State University, and other third-party organizations. What's the consensus opinion? The relatively mild herbicide poses no cause for concern.

Consumers should also consider that 2,4-D is already widely used not just in industrial agriculture, but also by everyday households. In fact, you've probably held a container of the herbicide by your side and may have even spilled some on your own hands. That's because the herbicide is the active ingredient in weed killers such as Scotts TurfBuilder. That's hardly a product that merits protests and widespread opposition.

Given the facts, consumers should know that the safety of food ingredients will not change if and when Enlist crop varieties are approved in the United States (they will be planted in Canada this year).   

Is there good news to the recommendation?
Actually, yes (sort of). The USDA believes that approving Enlist crops would lead to the adoption of less "aggressive tillage strategies", which release quite a bit of greenhouse gases and can cause water pollution and topsoil erosion, as food writer and author Nathanael Johnson of Grist pointed out.

G

As with any technology, too much tilling can be a bad thing. Image source: Ian Bailey

While the agency admitted that approval would result in "another two fold to six fold increase" in 2,4-D use by 2020, the eventual approval of Enlist crops will give American farmers another tool in managing the spread of resistant weeds -- a responsibility that, similar to managing pests, falls largely on their shoulders. Simply put, the ability to alternate between herbicides, such as 2,4-D from Dow and glyphosate from Monsanto, from one harvest to another will more effectively mitigate the emergence of resistant weeds when compared to a mono-herbicide approach.

The need for products such as Enlist corn and soybean varieties is also good news for shareholders, as they are expected to be a big product for Dow AgroSciences. The company has also developed a new formulation of herbicide called Enlist Duo that compliments the crop varieties and is under review by the EPA. Both products need approval before Enlist can be sold commercially. However, considering how well the Roundup Ready crops and Roundup herbicide pair performed for Monsanto and coupled with the widespread use of 2,4-D already, Enlist has the potential to be a tremendous growth catalyst for Dow. Investors may want to taper their expectations, since Dow AgroSciences is just a piece of The Dow Chemical Company, but considering that the company is one of three that produces 2,4-D globally, there's certainly reason for optimism.

Foolish bottom line
Dow AgroSciences isn't out of the woods yet. The USDA and EPA both need to green-light Enlist products after evaluating the risks under the regulatory eye of each respective agency. Nonetheless, years of safe use of the herbicide 2,4-D in industrial agriculture and households should alleviate fears of consumers worried about the chemical's historic (and unfortunate) association with Agent Orange. While there will undoubtedly be -- and has already been -- fierce opposition to the new biotech crops by anti-GMO groups, investors should expect approval to be followed by a blockbuster launch of Enlist products.

Are biotech crops too controversial for your portfolio?
Complimentary Enlist crops and herbicides won't provide the same growth for Dow as Roundup pairings did for Monsanto, but it should still be a great growth product. However, you may not want to expose your portfolio to such a controversial, albeit critical, industry. Luckily, while opportunities to get wealthy from a single investment don't come around often, they do exist, and our chief technology officer believes he's found one. In this free report, Jeremy Phillips shares the single company that he believes could transform not only your portfolio, but your entire life. To learn the identity of this stock for free and see why Jeremy is putting more than $100,000 of his own money into it, all you have to do is click here now.

Fool contributor Maxx Chatsko has no position in any stocks mentioned. Check out his personal portfolio, his CAPS page, or his previous writing.

The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.


Compare Brokers